NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001792

Registered date:24/03/2009

Effect of landiolol hydrochloride for prevention of atrial fibrillation after CABG: a randomised controlled trial

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedmyocardial infarction, angina
Date of first enrollment2008/10/01
Target sample size140
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)intra-and perioperative administration of landiolol hydrochloride intra-and perioperative non-administration of landiolol hydrochloride

Outcome(s)

Primary OutcomeIncidence of postoperative atrial fibrillation
Secondary Outcome1) age 2) Blood pressure, heart rate, CVP 3) IL-6, IL-8 4) CK-MB, Tp-I, H-FABP 5) Urinary-OHdG 6) hyaluronan, KL-6, angiotensin-II 7) mortality, complication

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteriapast of arrhythmia cardiogenic shock NYHA class IV congestive heart failure despite treatment sinus bradycardia at rest (<50/min) second -or third-degree AV block clinical hypothyroidism or hyperthyroidism Doctor's decision not to register to this regimen

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail
Affiliation Nihon University School of Medicine Department of Cardiovascular Surgery
scientific contact
Name Akira Sezai
Address 30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan Japan
Telephone 03-3972-8111
E-mail
Affiliation Nihon University school of medicine Department of Cardiovascular Surgery